These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20019149)

  • 1. Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations.
    Fothergill JL; Mowat E; Ledson MJ; Walshaw MJ; Winstanley C
    J Med Microbiol; 2010 Apr; 59(Pt 4):472-481. PubMed ID: 20019149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain.
    Fothergill JL; Panagea S; Hart CA; Walshaw MJ; Pitt TL; Winstanley C
    BMC Microbiol; 2007 May; 7():45. PubMed ID: 17521417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections.
    Mowat E; Paterson S; Fothergill JL; Wright EA; Ledson MJ; Walshaw MJ; Brockhurst MA; Winstanley C
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1674-9. PubMed ID: 21297072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensive diversification is a common feature of Pseudomonas aeruginosa populations during respiratory infections in cystic fibrosis.
    Ashish A; Paterson S; Mowat E; Fothergill JL; Walshaw MJ; Winstanley C
    J Cyst Fibros; 2013 Dec; 12(6):790-3. PubMed ID: 23642644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lytic activity by temperate phages of Pseudomonas aeruginosa in long-term cystic fibrosis chronic lung infections.
    James CE; Davies EV; Fothergill JL; Walshaw MJ; Beale CM; Brockhurst MA; Winstanley C
    ISME J; 2015 Jun; 9(6):1391-8. PubMed ID: 25461970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antibiotic treatment on bacteriophage production by a cystic fibrosis epidemic strain of Pseudomonas aeruginosa.
    Fothergill JL; Mowat E; Walshaw MJ; Ledson MJ; James CE; Winstanley C
    Antimicrob Agents Chemother; 2011 Jan; 55(1):426-8. PubMed ID: 20974862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolutionary diversification of Pseudomonas aeruginosa in an artificial sputum model.
    Davies EV; James CE; Brockhurst MA; Winstanley C
    BMC Microbiol; 2017 Jan; 17(1):3. PubMed ID: 28056789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in Italy.
    Cigana C; Melotti P; Baldan R; Pedretti E; Pintani E; Iansa P; De Fino I; Favari F; Bergamini G; Tridello G; Cirillo DM; Assael BM; Bragonzi A
    BMC Microbiol; 2016 Jul; 16(1):142. PubMed ID: 27400750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of methods to test antibiotic combinations against heterogeneous populations of multiresistant Pseudomonas aeruginosa from patients with acute infective exacerbations in cystic fibrosis.
    Foweraker JE; Laughton CR; Brown DF; Bilton D
    Antimicrob Agents Chemother; 2009 Nov; 53(11):4809-15. PubMed ID: 19704123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophages in sputum of cystic fibrosis patients as a possible cause of in vivo changes in serotypes of Pseudomonas aeruginosa.
    Ojeniyi B
    APMIS; 1988 Apr; 96(4):294-8. PubMed ID: 3130885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)--a cause for concern?
    Ashish A; Shaw M; Winstanley C; Ledson MJ; Walshaw MJ
    J Cyst Fibros; 2012 May; 11(3):173-9. PubMed ID: 22146482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic relatedness of Pseudomonas aeruginosa isolates among a paediatric cystic fibrosis patient cohort in Ireland.
    Logan C; Habington A; Lennon G; Grogan J; Byrne M; O'Leary J; O'Sullivan N
    J Med Microbiol; 2012 Jan; 61(Pt 1):64-70. PubMed ID: 21921114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing.
    Foweraker JE; Laughton CR; Brown DF; Bilton D
    J Antimicrob Chemother; 2005 Jun; 55(6):921-7. PubMed ID: 15883175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombination is a key driver of genomic and phenotypic diversity in a Pseudomonas aeruginosa population during cystic fibrosis infection.
    Darch SE; McNally A; Harrison F; Corander J; Barr HL; Paszkiewicz K; Holden S; Fogarty A; Crusz SA; Diggle SP
    Sci Rep; 2015 Jan; 5():7649. PubMed ID: 25578031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Sweeps and Parallel Pathoadaptation Drive Pseudomonas aeruginosa Evolution in the Cystic Fibrosis Lung.
    Diaz Caballero J; Clark ST; Coburn B; Zhang Y; Wang PW; Donaldson SL; Tullis DE; Yau YC; Waters VJ; Hwang DM; Guttman DS
    mBio; 2015 Sep; 6(5):e00981-15. PubMed ID: 26330513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance.
    Sousa AM; Monteiro R; Pereira MO
    Int J Med Microbiol; 2018 Dec; 308(8):1053-1064. PubMed ID: 30377031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease.
    Thomas SR; Ray A; Hodson ME; Pitt TL
    Thorax; 2000 Sep; 55(9):795-7. PubMed ID: 10950901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial cyanogenesis occurs in the cystic fibrosis lung.
    Sanderson K; Wescombe L; Kirov SM; Champion A; Reid DW
    Eur Respir J; 2008 Aug; 32(2):329-33. PubMed ID: 18480103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
    Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
    AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient.
    Workentine ML; Sibley CD; Glezerson B; Purighalla S; Norgaard-Gron JC; Parkins MD; Rabin HR; Surette MG
    PLoS One; 2013; 8(4):e60225. PubMed ID: 23573242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.